Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 19 (ZNF19, KOX12) is a member of the large zinc finger protein family, characterized by its classical C2H2 domain, which stabilizes its structure and allows for flexible binding to various substrates—including DNA and RNA. Zinc finger proteins are among the most abundant transcription factor families, participating in transcription regulation, chromatin remodeling, and nucleic acid interactions. ZNF19 likely functions as a transcription factor, regulating gene expression through DNA binding, but its specific biological roles and implications in human disease are not fully elucidated[4][1][2][3]. No existing evidence designates ZNF19 as a drug target or clinical biomarker, nor are there associated safety concerns in therapeutic contexts. The broader zinc finger protein family does include members involved in disease pathology, including cancer and neurodegeneration, though direct links for ZNF19 have not been reported in current literature[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 19 (ZNF19).